Pierre Bourdillon1, Philippe Ryvlin2, Jean Isnard3, Alexandra Montavont4, Hélène Catenoix5, François Mauguière6, Sylvain Rheims7, Karine Ostrowsky-Coste8, Marc Guénot9. 1. Department of Neurosurgery, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France; Université Claude Bernard, University of Lyon, Lyon, France; Université Pierre et Marie Curie, Sorbonne University, Paris, France; Brain and Spine Institute, INSERM U1127, CNRS, UMR7225, Paris France. 2. CHUV, Department of Clinical Neurosciences, Lausanne, Switzerland; Neuroscience Research Center of Lyon, INSERM U1028, CNRS 5292, Lyon, France. 3. Neuroscience Research Center of Lyon, INSERM U1028, CNRS 5292, Lyon, France; Department of Functional Neurology and Epileptology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France. 4. Department of Functional Neurology and Epileptology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France; Department of Sleep, Epilepsy and Pediatric Clinical Neurophysiology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France. 5. Department of Functional Neurology and Epileptology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France. 6. Université Claude Bernard, University of Lyon, Lyon, France; Department of Functional Neurology and Epileptology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France. 7. Université Claude Bernard, University of Lyon, Lyon, France; Neuroscience Research Center of Lyon, INSERM U1028, CNRS 5292, Lyon, France; Department of Functional Neurology and Epileptology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France. 8. Department of Sleep, Epilepsy and Pediatric Clinical Neurophysiology, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France. 9. Department of Neurosurgery, Hospital for Neurology and Neurosurgery Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France; Université Claude Bernard, University of Lyon, Lyon, France; Neuroscience Research Center of Lyon, INSERM U1028, CNRS 5292, Lyon, France.
Abstract
BACKGROUND: In some cases of drug-resistant focal epilepsy, noninvasive presurgical investigation may be insufficient to identify the ictal onset zone and the eloquent cortical areas. In such situations, invasive investigations are proposed using either stereotactic electroencephalography (SEEG) or subdural grid electrodes. Meta-analysis suggests that SEEG is safer than subdural grid electrodes, but insular implantation of SEEG electrodes has been thought to carry an additional risk of intraparenchymal hemorrhagic complications. Our objectives were to determine whether an insular SEEG trajectory is a risk factor for intracranial hematoma and to report the global safety of the procedure and provide some guidelines to prevent and detect complications. METHODS: In a retrospective analysis of a surgical series of 525 consecutive procedures between 1995 and 2015, all electrodes were classified according to their insular or extrainsular trajectory. All complications were classified as major or minor according to their potential consequences regarding patient neurologic status. RESULTS: Four intraparenchymal hematomas, all related to extrainsular electrodes (4/4974; 0.08%) were reported; no hematoma was found along insular electrodes (0/1042; 0%). There were 8 major complications (1.52%): 7 intracranial hematomas (1.33%) and 1 case of meningitis. Two patients had long-term neurologic impairment (0.38%), and 1 death (not directly related to the procedure) occurred (0.19%). Eleven minor complications (2.09%) were encountered, including broken electrode (1.52%), acute pneumocephalus (0.38%), and local cutaneous infection (0.19%). CONCLUSIONS: SEEG is a safe procedure. Insular trajectories cannot be considered an additional risk of intracranial bleeding.
BACKGROUND: In some cases of drug-resistant focal epilepsy, noninvasive presurgical investigation may be insufficient to identify the ictal onset zone and the eloquent cortical areas. In such situations, invasive investigations are proposed using either stereotactic electroencephalography (SEEG) or subdural grid electrodes. Meta-analysis suggests that SEEG is safer than subdural grid electrodes, but insular implantation of SEEG electrodes has been thought to carry an additional risk of intraparenchymal hemorrhagic complications. Our objectives were to determine whether an insular SEEG trajectory is a risk factor for intracranial hematoma and to report the global safety of the procedure and provide some guidelines to prevent and detect complications. METHODS: In a retrospective analysis of a surgical series of 525 consecutive procedures between 1995 and 2015, all electrodes were classified according to their insular or extrainsular trajectory. All complications were classified as major or minor according to their potential consequences regarding patient neurologic status. RESULTS: Four intraparenchymal hematomas, all related to extrainsular electrodes (4/4974; 0.08%) were reported; no hematoma was found along insular electrodes (0/1042; 0%). There were 8 major complications (1.52%): 7 intracranial hematomas (1.33%) and 1 case of meningitis. Two patients had long-term neurologic impairment (0.38%), and 1 death (not directly related to the procedure) occurred (0.19%). Eleven minor complications (2.09%) were encountered, including broken electrode (1.52%), acute pneumocephalus (0.38%), and local cutaneous infection (0.19%). CONCLUSIONS: SEEG is a safe procedure. Insular trajectories cannot be considered an additional risk of intracranial bleeding.
Authors: Hepzibha Alexander; Kelsey Cobourn; Islam Fayed; Dewi Depositario-Cabacar; Robert F Keating; William D Gaillard; Chima O Oluigbo Journal: Childs Nerv Syst Date: 2019-01-09 Impact factor: 1.475
Authors: Angélique Volfart; Jacques Jonas; Louis Maillard; Sophie Colnat-Coulbois; Bruno Rossion Journal: PLoS Biol Date: 2020-04-03 Impact factor: 8.029
Authors: Mohamed Tantawi; Jingya Miao; Caio Matias; Christopher T Skidmore; Michael R Sperling; Ashwini D Sharan; Chengyuan Wu Journal: Front Neurol Date: 2021-04-27 Impact factor: 4.003
Authors: Lars E van der Loo; Olaf E M G Schijns; Govert Hoogland; Albert J Colon; G Louis Wagner; Jim T A Dings; Pieter L Kubben Journal: Acta Neurochir (Wien) Date: 2017-07-05 Impact factor: 2.216